DOI QR코드

DOI QR Code

Associations Between Three Polymorphisms in the Interleukin-4 Receptor Gene and Risk of Cancer: a Meta-analysis

  • Wang, Jia-Yi (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) ;
  • Zhou, Yu-Qiao (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) ;
  • Li, Xiao-Xu (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) ;
  • Jin, Xin (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) ;
  • Wang, Li-Li (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) ;
  • Lei, Lei (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) ;
  • Zhou, Yu (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) ;
  • Lu, Jiang (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) ;
  • Zeng, Xin (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) ;
  • Dan, Hong-Xia (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) ;
  • Liao, Ga (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) ;
  • Chen, Qian-Ming (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University)
  • Published : 2012.12.31

Abstract

Interleukin-4 receptor (IL-4R) gene single nucleotide polymorphisms (SNPs) are implicated in cancer development. However, results from the published reports have remained inconclusive. The objective of this study was to conduct a meta-analysis investigating the association between polymorphisms in IL-4R gene and cancer risk. Pubmed, EMBASE and China National Knowledge Infrastructure (CNKI) were searched for case-control studies published up to October 30, 2012 that investigated IL-4R polymorphisms and cancer risk. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the strength of any associations. Three IL-4R polymorphisms (Q576R, rs1801275; I75V, rs1805010; S503P, rs1805015) in 21 case-control studies were analyzed. Our meta-analysis indicated that these three polymorphisms are not associated with cancer risk when all studies were pooled together. In the subgroup analysis by tumor site, the results showed that Q576R G allele carriers were associated with a significantly decreased cervical cancer risk (recessive model: OR = 0.77, 95%CI = 0.60-0.98; homozygote comparison: OR = 0.76, 95%CI = 0.58-0.98). I75V G allele carriers were associated with a decreased risk of renal cancer (dominant model = 0.71, 95%CI = 0.57-0.89, heterozygote comparison: OR = 0.69, 95%CI = 0.55-0.87). When stratified by ethnicity, Q576R G allele carriers were associated with a decreased cancer risk in Caucasians (dominant model: OR = 0.90, 95%CI = 0.83-0.98; heterozygote comparison: OR = 0.89, 95%CI = 0.82-0.98). I75V G allele carriers were associated with a decreased cancer risk in Asians (heterozygote comparison: OR = 0.76, 95%CI = 0.62-0.94). S503P C allele carriers were also associated with a decreased cancer risk in Asians (CC VS TT: OR = 0.29, 95%CI = 0.08-0.99). Our results suggest that Q576R, I75V and S503P may be associated with a decreased cancer risk for certain types of cancers and in some specific ethnic groups. Future case-control studies with large sample size are needed to evaluate these associations in detail.

Keywords

Cancer;interleukin-4 receptor;polymorphisms;meta-analysis

References

  1. Sim SH, Ahn YO, Yoon J, et al (2012). Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of nonsmall cell lung cancer. Cancer Sci, 103, 155-60. https://doi.org/10.1111/j.1349-7006.2011.02158.x
  2. Wei BB, Xi B, Wang R, et al (2010). TGFbeta1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies. Cancer Genet Cytogenet, 196, 68-75. https://doi.org/10.1016/j.cancergencyto.2009.09.016
  3. Welsh MM, Karagas MR, Kuriger JK, et al (2011). Genetic determinants of UV-susceptibility in non-melanoma skin cancer. PLoS One, 6, e20019. https://doi.org/10.1371/journal.pone.0020019
  4. Wilkening S, Tavelin B, Canzian F, et al (2008). Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis, 29, 1202-06. https://doi.org/10.1093/carcin/bgn101
  5. Xia HZ, Du WD, Wu Q, et al (2011). E-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population. Mol Carcinog, 51, 597-607.
  6. Johnson LG, Schwartz SM, Malkki M, et al (2011). Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster. Cancer Epidemiol. Biomarkers Prev, 20, 199-207. https://doi.org/10.1158/1055-9965.EPI-10-0779
  7. Mitsuyasu H, Izuhara K, Mao XQ, et al (1998). Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet, 19, 119-20. https://doi.org/10.1038/472
  8. Mohan S, Mohanasenthil, Paul SF, Shroff S, Venkatesan V (2009). Interleukin-4-receptor alpha gene polymorphism and the risk of renal cell carcinoma in a South Indian population. Asian Pac J Cancer Prev, 10, 295-8.
  9. Nakamura E, Megumi Y, Kobayashi T, et al (2002). Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population. Clin. Cancer Res, 8, 2620-5.
  10. Obiri NI, Hillman GG, Haas GP, Sud S, Puri RK (1993). Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J Clin Invest, 91, 88-93. https://doi.org/10.1172/JCI116205
  11. Obiri NI, Siegel JP, Varricchio F, Puri RK (1994). Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin Exp Immunol, 95, 148-55.
  12. Olson SH, Orlow I, Simon J, et al (2007). Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer. Cancer Detect Prev, 31, 345-51. https://doi.org/10.1016/j.cdp.2007.10.002
  13. Onishi T, Ohishi Y, Imagawa K, Ohmoto Y, Murata K (1999). An assessment of the immunological environment based on intratumoral cytokine production in renal cell carcinoma. BJU Int, 83, 488-92.
  14. Ruan Z, Zhao Y, Yan L, et al (2011). Single nucleotide polymorphisms in IL-4Ra, IL-13 and STAT6 genes occurs in brain glioma. Front Biosci, 3, 33-45. https://doi.org/10.2741/e217
  15. Sarpatwari A, Bussel JB, Ahmed M, et al (2011). Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults. Hematology, 16, 243-8. https://doi.org/10.1179/102453311X13025568941808
  16. Schwartzbaum J, Ahlbom A, Malmer B, et al (2005). Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res, 65, 6459-65. https://doi.org/10.1158/0008-5472.CAN-04-3728
  17. Schwartzbaum JA, Ahlbom A, Lonn S, et al (2007). An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol. Biomarkers Prev, 16, 2448-54. https://doi.org/10.1158/1055-9965.EPI-07-0480
  18. Seno H, Satoh K, Tsuji S, et al (2007). Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: comprehensive analysis of 207 polymorphisms of 11 cytokine genes. J. Gastroenterol. Hepatol, 22, 729-37. https://doi.org/10.1111/j.1440-1746.2007.04934.x
  19. Sheu BC, Chang WC, Cheng CY, et al (2008). Cytokine regulation networks in the cancer microenvironment. Front Biosci, 13, 6255-68.
  20. Ali KS, Ali HY, Jubr ael JM (2012). Concentration levels of IL-10 and TNF alpha cytokines in patients with human papilloma virus (HPV) DNA(+) and DNA(-) cervical lesions. J Immunotoxicol, 9, 168-72. https://doi.org/10.3109/1547691X.2011.642419
  21. Ames BN, Gold LS, Willett WC (1995). The causes and prevention of cancer. Proc Natl Acad Sci USA, 92, 5258-65. https://doi.org/10.1073/pnas.92.12.5258
  22. Balasubramanian SP, Azmy IA, Higham SE, et al (2006). Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer, 6, 188. https://doi.org/10.1186/1471-2407-6-188
  23. Brenner AV, Butler MA, Wang SS, et al (2007). Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis, 28, 2543-7. https://doi.org/10.1093/carcin/bgm210
  24. Brown EE, Lan Q, Zheng T, Zhang Y, et al (2007). Common variants in genes that mediate immunity and risk of multiple myeloma. Int. J. Cancer, 120, 2715-22. https://doi.org/10.1002/ijc.22618
  25. Castro FA, Haimila K, Sareneva I, et al (2009). Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach. Int. J. Cancer, 125, 1851-8. https://doi.org/10.1002/ijc.24529
  26. Chu H, Ma L, Wang M, Shi D, et al (2012). The polymorphisms of IL-4, IL-4R and IL-13 genes and bladder cancer risk in a Chinese population: a case-control study. Mol Biol Rep, 39, 5349-57. https://doi.org/10.1007/s11033-011-1334-9
  27. Chu H, Wang M, Yan F, et al (2012). Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma. Ann. Oncol, 23, 2114-21.
  28. de Visser KE, Eichten A, Coussens LM (2006). Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer, 6, 24-37. https://doi.org/10.1038/nrc1782
  29. Engle LJ, Simpson CL, Landers JE (2006). Using high-throughput SNP technologies to study cancer. Oncogene, 25, 1594-601. https://doi.org/10.1038/sj.onc.1209368
  30. Gooch JL, Christy B, and Yee D (2002). STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells. Neoplasia, 4, 324-31. https://doi.org/10.1038/sj.neo.7900248
  31. Grivennikov SI, Greten FR, Karin M (2010). Immunity, inflammation, and cancer. Cell, 140, 883-99. https://doi.org/10.1016/j.cell.2010.01.025
  32. Hamajima N, Matsuo K, Saito T, et al (2001). Gene-environment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II). Asian Pac J Cancer Prev, 2, 99-107.
  33. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70. https://doi.org/10.1016/S0092-8674(00)81683-9
  34. Ivansson EL, Gustavsson IM, Magnusson JJ, et al (2007). Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer. Int J Cancer, 121, 2451-7. https://doi.org/10.1002/ijc.22989

Cited by

  1. Role of Cytokines in Genesis, Progression and Prognosis of Cervical Cancer vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.3851